The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data

BACKGROUND: Spurred by success in several foci, onchocerciasis control policy in Africa has shifted from morbidity control to elimination of infection. Clinical trials have demonstrated that moxidectin is substantially more efficacious than ivermectin in effecting sustained reductions in skin microf...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Parasit Vectors
Autors principals: Turner, Hugo C, Walker, Martin, Attah, Simon K, Opoku, Nicholas O, Awadzi, Kwablah, Kuesel, Annette C, Basáñez, María-Gloria
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4381491/
https://ncbi.nlm.nih.gov/pubmed/25889256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-015-0779-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars